Regulations.gov document
Exhibit 2 to Supplement to CP from Ropes & Gray LLP (Pfizer Inc.) to FDA CDER
Supporting & Related Material · FDA-2016-P-3082 · posted Mar 31, 2017
Key facts
| Document ID | FDA-2016-P-3082-0017 |
|---|---|
| Title | Exhibit 2 to Supplement to CP from Ropes & Gray LLP (Pfizer Inc.) to FDA CDER |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2016-P-3082 |
| Posted | Mar 31, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: